Exploring the Clinical Significance of Circulating H19 lncRNA and IGF-2 mRNA in Colorectal Carcinoma
Plasma H19 lncRNA and IGF-2 mRNA may be a marker of tumor burden in CRC, while H19 lncRNA is also an indicator of CRC progression, which, if confirmed, can be used in the clinical management of CRC patients.
Authors
- Cemil Burak Kulle (ORCID: https://orcid.org/0000-0003-2956-4486)
- Ebru Esin Yörüker (ORCID: https://orcid.org/0000-0002-2809-5975)
- Uğur Gezer (ORCID: https://orcid.org/0000-0001-8471-5254)
- Mehmet Çiftçi (ORCID: https://orcid.org/0000-0002-1748-3729)
- Emre Özgür (ORCID: https://orcid.org/0000-0002-4995-4759)
Institutions
- Istanbul University (TR)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-09-26
- DOI
- https://doi.org/10.21873/anticanres.17775
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00